{"result": "(\"entity\"<|>JOHN HOPKINS UNIVERSITY<|>ORGANIZATION<|>Johns Hopkins University is a private research university located in Baltimore, known for its contributions to various fields including medicine and public health.)\n##\n(\"entity\"<|>AMERICAN SOCIETY FOR PARENTERAL AND ENTERAL NUTRITION<|>ORGANIZATION<|>The American Society for Parenteral and Enteral Nutrition is a professional organization focused on advancing the science and practice of clinical nutrition.)\n##\n(\"entity\"<|>GLYCOGEN STORAGE DISEASE TYPE III<|>EVENT<|>Glycogen storage disease type III is a metabolic disorder characterized by the body's inability to break down glycogen, leading to various health complications.)\n##\n(\"entity\"<|>LACTOSE MALABSORPTION<|>EVENT<|>Lactose malabsorption is a condition where the body cannot properly digest lactose, leading to gastrointestinal symptoms.)\n##\n(\"entity\"<|>GALACTOSEMIA<|>EVENT<|>Galactosemia is a genetic disorder that affects the body's ability to process galactose, a sugar found in milk and dairy products.)\n##\n(\"entity\"<|>LACTASE DEFICIENT INDIVIDUALS<|>PERSON<|>Individuals who lack sufficient lactase enzyme to digest lactose, leading to lactose intolerance.)\n##\n(\"relationship\"<|>JOHN HOPKINS UNIVERSITY<|>GLYCOGEN STORAGE DISEASE TYPE III<|>Johns Hopkins University conducts research and provides information on glycogen storage diseases, including type III<|>5)\n##\n(\"relationship\"<|>AMERICAN SOCIETY FOR PARENTERAL AND ENTERAL NUTRITION<|>GLYCOGEN STORAGE DISEASE TYPE III<|>The American Society for Parenteral and Enteral Nutrition provides guidelines and support for dietary management of glycogen storage diseases<|>5)\n##\n(\"relationship\"<|>LACTOSE MALABSORPTION<|>LACTASE DEFICIENT INDIVIDUALS<|>Lactose malabsorption is a common condition among lactase deficient individuals<|>8)\n##\n(\"relationship\"<|>GALACTOSEMIA<|>LACTASE DEFICIENT INDIVIDUALS<|>Galactosemia affects individuals who may also be lactose intolerant, as both conditions involve issues with sugar metabolism<|>4)\n##\n(\"relationship\"<|>GLYCOGEN STORAGE DISEASE TYPE III<|>LACTASE DEFICIENT INDIVIDUALS<|>Dietary management for glycogen storage disease type III may involve considerations for lactose intolerance<|>3)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: sphosphatase        deficiency.     J  Inherit   Metab      Dis.\n     1988; 48:1079.                                                               2010; 33:25-31.\n28.  Turk D. Soy protein for infant feeding: what do we                     41.   Huidekoper HH, Ackermans MT, Ruiter AF, Sauer-\n     know? Curr Opin Clin Nutr Metab Care. 2007;                                  wein HP, Wijburg FA. Endogenous glucose produc-\n     10:360-365.                                                                  tion from infancy to adulthood: a non-linear regres-\n29.  Lerebours E, Nâ€™Djitoyap Ndam C, Lavoine A, Hellot                            sion model. Arch Dis Child. 2014; 99:1098-1102.\n     MF, Antoine JM, Colin R. Yogurt and fermen-                            42.   Sentner PC, Hoogeveen IJ, Weinstein DA, Santer R,\n     ted-then-pasteurized         milk:   effects   of   shortterm                Murphy E, McKiernan PJ, et al. Glycogen storage\n     and long-term ingestion on lactose absorption                                disease    type   III: diagnosis,     genotype,      manage-\n     and mucosal lactase activity in lactase-deficient                            ment, clinical course and outcome. J Inherit Metab\n     subjects. Am J Clin Nutr. 1989; 49:823-7.                                    Dis. 2016; 39:697-704.\n30.  Pochart P, Dewit O, Desjeux JF, Bourlioux P. Viable                    43.   Shah KK, Oâ€™Dell SD. Effect of dietary interventions\n     starter culture, Î²-galactosidase activity, and lacto-                        in the maintenance of normoglycaemia in glyco-\n     se in duodenum after yogurt ingestion in lacta-                              gen storage disease type 1a: a systematic review\n     se-deficient     humans.       Am    J   Clin   Nutr.    1989;               and meta-analysis. J Hum Nutr Diet. 2013 Aug;\n     49:828-31.                                                                   26(4):329-39.\n31.  Savaiano DA, AbouElAnouar A, Smith DE, Levitt                          44.   Mayorandan S, Meyer U Hartmann H, Das AM.\n     MD. Lactose malabsorption from yogurt, pasteur-                              Glycogen storage disease type III: modified Atkins\n     ized yogurt, sweet acidophilus milk, and cultured                            diet improves myopathy. Orphanet J Rare Dis.\n     milk   in  lactase-deficient      individuals.     Am    J  Clin             2014; 9:196.\n     Nutr. 1984; 40:1219-23.                                                45.   Brambilla A, Mannarino S, Pretese R, Gasperini S,\n32.  Hickey MW, Hillier AJ, Jago GR. Transport and me-                            Galimberti C, Parini R. Improvement of cardiomyo-\n     tabolism of lactose, glucose, and galactose in ho-                           pathy after high-fat diet in two siblings with gly-\n     mofermentative lactobacilli. Appl Environ Microbi-                           cogen storage disease type III. JIMD Rep. 2014;\n     ol. 1986; 51:825-31                                                          17:91-5.\n33.  Foucaud C, Poolman B. Lactose transport system                         46.   Valayannopoulos V, Bajolle F, Arnoux JB, Dubois S,\n     of Streptococcus thermophilus. J Biol Chem. 1992;                            Sannier N, Baussan C, et al. Succesful treatment of\n     267:22087-94.                                                                severe cardiomyopathy in glycogen storage disease\n34.  Online     Mendelian       Inheritance     in  Man,     OMIM                 type III with D,L-3-Hydroxybutyrate, ketogenic and\n     (TM). John Hopkins University, Baltimore. NCBI.                              high-protein diet. Pediatr Res. 2011; 70:638-641.\n35.  Ling, McCowen. Carbohydrates. The A.S.P.E.N. nu-                       47.   Gross KC, Acosta PB. Fruits and vegetables are a\n     trition support core curriculum: A case-based ap-                            source of galactose: implications in planning the\n     proach- The adult patient. Gottschlich, De Legge,                            diets of patients with galactosaemia. J Inher Me-\n     Mattox, Mueller, Worthington. American Society                               tab Dis. 1991;14:253-258.\n     for Parenteral and Enteral Nutrition. 2nd Edition.                     48.   Puntis JW, Zamvar V. Congenital sucrase-isomalta-\n36.  MartÃ­nez AugustÃ­n, Puerta FernÃ±andez, SuÃ¡rez Or-                             se deficiency: diagnostic challenges and response\n     tega. Metabolismo de los hidratos de carbono.                                to enzyme replacement therapy. Arch Dis Child.\n     Tomo I. Tratado de NutriciÃ³n. Gil HernÃ¡ndez, SÃ¡n-                            2015; 100(9):869-71.\n     chez de\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}